Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Hepatitis C Virus Genotype 1”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT02624063
What this trial is testing

Randomized Clinical Trial of Sofosbuvir in Combination With Daclatasvir or Simeprevir for 12 Weeks in Non-cirrhotic Subjects Infected With Chronic Hepatitis C Virus Genotype 1 (TNT)

Who this might be right for
Hepatitis C, Chronic
Federal University of São Paulo 121
Large-scale testing (Phase 3)Study completedNCT03219216
What this trial is testing

Evaluate the Efficacy and Safety of Glecaprevir (GLE)/Pibrentasvir (PIB) in Treatment-Naive Adults in Brazil With Chronic Hepatitis C Virus (HCV) Genotype 1 - 6 Infection

Who this might be right for
Hepatitis C Virus (HCV)
AbbVie 100
Testing effectiveness (Phase 2)Study completedNCT03020095
What this trial is testing

Efficacy and Safety of Ravidasvir + Danoprevir/r 12-week Oral Therapy in Treatment-Naive Non Cirrhotic G1 CHC Taiwan

Who this might be right for
Chronic Hepatitis C
Ascletis Pharmaceuticals Co., Ltd. 38
Large-scale testing (Phase 3)Study completedNCT02442271
What this trial is testing

Evaluate the Efficacy and Safety of Three Experimental Drugs in Adults With Hepatitis C Virus Infection, Who Are Either Treatment-naive or Treatment-experienced in Brazil

Who this might be right for
Chronic Hepatitis C Infection
AbbVie 222
Not applicableStudy completedNCT03740230
What this trial is testing

An Observational Study of Maviret (Glecaprevir/Pibrentasvir) for Korean Chronic Hepatitis C Genotypes 1 to 6 Patients According to the Standard for Re-examination of New Drugs

Who this might be right for
Hepatitis C
AbbVie 3,134
Testing effectiveness (Phase 2)Study completedNCT01849562
What this trial is testing

Safety, Tolerability, and Efficacy of 12-weeks of Sovaprevir, ACH-3102, and Ribavirin in Treatment-naive GT-1 HCV Participants

Who this might be right for
Hepatitis C, Chronic
Alexion Pharmaceuticals, Inc. 30
Large-scale testing (Phase 3)Study completedNCT02692703
What this trial is testing

Evaluate the Safety and Efficacy of ABT-493/ABT-530 in Adult Post-Liver or Post-Renal Transplant Recipients With Chronic Hepatitis C Virus (MAGELLAN-2)

Who this might be right for
Chronic Hepatitis CHCVHepatitis C Virus
AbbVie 100
Large-scale testing (Phase 3)Study completedNCT02219477
What this trial is testing

Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Ribavirin in Adults With Genotype 1 and Ombitasvir/Paritaprevir/Ritonavir With Ribavirin in Adults With Genotype 4 Chronic Hepatitis C Virus Infection and Decompensated Cirrhosis

Who this might be right for
Chronic Hepatitis CDecompensated CirrhosisHepatitis C Virus
AbbVie 36
Not applicableStudy completedNCT02098616
What this trial is testing

Rapid Hepatitis C Elimination Trial- A Pilot Study of Daclatasvir/Asunaprevir/BMS-791325 With or Without Ribavirin To Treat Hepatitis C Virus

Who this might be right for
Hepatitis C
Timothy Morgan, MD 25
Large-scale testing (Phase 3)WithdrawnNCT01890200
What this trial is testing

The Effects of Adding TCM-700C on the Standard Combination Treatment for HCV Genotype 1 Patients(Phase III)

Who this might be right for
Chronic Hepatitis C
TCM Biotech International Corp.
Testing effectiveness (Phase 2)WithdrawnNCT01142700
What this trial is testing

BMS-824393 in Combination With Peginterferon Alfa-2a (Pegasys) and Ribavirin (Copegus) in Treatment Naive Subjects With Chronic Hepatitis C Virus Genotype I

Who this might be right for
Chronic Hepatitis C Virus Genotype 1
Bristol-Myers Squibb
Testing effectiveness (Phase 2)Study completedNCT01314261
What this trial is testing

Study of ABT-267 in Treatment Naive Hepatitis C Virus (HCV) Genotype 1 Infected Subjects

Who this might be right for
Chronic Hepatitis CHepatitis C Virus (HCV) Infection
AbbVie (prior sponsor, Abbott) 37
Large-scale testing (Phase 3)Study completedNCT01513941
What this trial is testing

An Efficacy and Safety Study of Telaprevir in Patients Infected With Both Chronic Hepatitis C Virus (HCV-1) and Human Immunodeficiency Virus (HIV-1)

Who this might be right for
Chronic Hepatitis C
Janssen-Cilag International NV 163
Large-scale testing (Phase 3)Study completedNCT02219490
What this trial is testing

Evaluate Long-term Outcomes Following Treatment With ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection

Who this might be right for
Chronic Hepatitis C Virus (HCV) Infection Genotype 1
AbbVie 1,596
Testing effectiveness (Phase 2)Study completedNCT00277238
What this trial is testing

CPG10101 Combination Therapy For The Treatment Of Hepatitis C In Non-Responder (Null And Partial Responder) Hepatitis C Virus (HCV) Genotype 1 Infected Subjects

Who this might be right for
Hepatitis, Chronic Active
Pfizer 113
Testing effectiveness (Phase 2)Study completedNCT01074008
What this trial is testing

Study to Evaluate the Safety, Tolerability and Antiviral Activity of ABT-450, ABT-333 and ABT-072

Who this might be right for
Hepatitis CHCVChronic Hepatitis C Infection+1 more
AbbVie (prior sponsor, Abbott) 74
Testing effectiveness (Phase 2)Study completedNCT01180790
What this trial is testing

Safety, Tolerability, and Antiviral Activity of ACH-0141625 or Placebo in Combination With Peginterferon and Ribavirin in Hepatitis C Virus (HCV) Positive Participants

Who this might be right for
Hepatitis C
Alexion Pharmaceuticals, Inc. 122
Large-scale testing (Phase 3)Study completedNCT01732796
What this trial is testing

IFN-free Combination Therapy in HCV-infected Patients Treatment-naive:HCVerso1

Who this might be right for
Hepatitis C, Chronic
Boehringer Ingelheim 470
Testing effectiveness (Phase 2)Study completedNCT02421211
What this trial is testing

Investigate the Pharmacokinetic Interactions Between Simeprevir and Ledipasvir in a Treatment Regimen Consisting of Simeprevir, Sofosbuvir, and Ledipasvir in Treatment-naive Participants With Chronic Hepatitis C Virus Genotype 1 Infection

Who this might be right for
Hepatitis C, Chronic
Janssen Sciences Ireland UC 41
Testing effectiveness (Phase 2)Study completedNCT02457611
What this trial is testing

Safety and Efficacy of Ledipasvir/Sofosbuvir (LDV/SOF) Fixed-Dose Combination (FDC) for 6 Weeks in Adults With Acute Genotype 1 or 4 Hepatitis C Virus (HCV) and Chronic Human Immunodeficiency Virus (HIV)-1 Co-Infection

Who this might be right for
Hepatitis C Infection With HIV Co-Infection
Gilead Sciences 26
Next Page